LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Mise à jour : Il y a 4 ans
Référence : NCT01726933

Femme et Homme

Extrait

The aim of the study is to evaluate the efficacy and safety of LAS41008 in comparison to active control and placebo in patients with moderate to severe chronic plaque psoriasis


Critère d'inclusion

  • Plaque psoriasis


Liens